MPWT
DICE

MassMutual Private Wealth & Trust’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30
Closed -$1K – 1903
2022
Q3 		$1K Hold
30
– – ﹤0.01% 1597
2022
Q2 		$0 Buy
+30
New +$516 ﹤0.01% 1775

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

MassMutual Private Wealth & Trust's DICE Position: Q4 2022 in Review

MassMutual Private Wealth & Trust sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q4 2022, closing a stake of 30 shares — an estimated $1K sold.

MassMutual Private Wealth & Trust first reported a position in DICE in Q2 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 109 funds tracked by Wall St. Rank hold DICE as of Q4 2022.

  • MassMutual Private Wealth & Trust reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 30 DICE Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $1K.
  • MassMutual Private Wealth & Trust first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • MassMutual Private Wealth & Trust's DICE Therapeutics, Inc. Common Stock position peaked at $1K in Q3 2022.
  • 109 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q4 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2022, filed 6 Jan 2023.